Taysha Gene Therapies, Inc. (TSHA)
NASDAQ: TSHA · Real-Time Price · USD
2.545
+0.175 (7.38%)
May 15, 2025, 1:50 PM - Market open
Taysha Gene Therapies Employees
Taysha Gene Therapies had 73 employees as of December 31, 2024. The number of employees increased by 21 or 40.38% compared to the previous year.
Employees
73
Change (1Y)
21
Growth (1Y)
40.38%
Revenue / Employee
$98,959
Profits / Employee
-$1,188,575
Market Cap
521.86M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 73 | 21 | 40.38% |
| Dec 31, 2023 | 52 | -13 | -20.00% |
| Dec 31, 2022 | 65 | -113 | -63.48% |
| Dec 31, 2021 | 178 | 140 | 368.42% |
| Dec 31, 2020 | 38 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
TSHA News
- 5 hours ago - Taysha Gene Therapies Reports First Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 6 days ago - Taysha Gene Therapies to Release First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 15 - GlobeNewsWire
- 13 days ago - Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 6 weeks ago - Drug stocks sink as FDA's top vaccine official is ousted in Trump overhaul - New York Post
- 2 months ago - Taysha Gene Therapies, Inc. (TSHA) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Taysha Gene Therapies Reports Full-Year 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 3 months ago - Taysha Gene Therapies to Release Full-Year 2024 Financial Results and Host Conference Call and Webcast on February 26 - GlobeNewsWire
- 3 months ago - Taysha Gene Therapies Is Showing Promise For Rett Syndrome - Seeking Alpha